---
granola_id: f415e67c-d08a-41bb-853a-acf26d713abc
title: "Virtue <> Prism"
type: note
created: 2025-06-03T18:37:51.813Z
updated: 2025-06-03T19:06:59.343Z
attendees:
  - jana@goprismhealth.com
  - jake@goprismhealth.com
---
### Team Background

#### Jacob

- Left UW, biotech, different pharma roles
- Product Manager for Data AI and genome sciences at Merck before leaving
- Saw persistent problems with outdated systems across companies
- Found Jana and Clement at Antler

#### Jana

- Found all the same problems across industry
- Background: Thermal systems as mechanical engineer, consulting and national lab work
- PhD in physiology studying prostheses usage
- Went through CU accelerator program - learned difference between idea/product vs business
- Started multiple companies during grad school focused on medical devices + digital health
- Met Jacob and Clement at Antler and joined forces

### Market Problem & Solution

- The market actively demanding better solutions - universal frustration with current processes
- Key pain point: No transparency into trials until too late
- Current issues: Spent millions and years before knowing asset doesn’t work
- CROs taking 6-12 months just to set up studies

### Product Focus: “# of taskss automated - moving to market exponentially faster”

- Automation as North Star metric
- Documentation automation as first priority
- Financials identified as biggest ROI for customers
- Platform features:
	- Unification layer - completely novel offering
	- Financial management - solving manual invoicing and payment validation
	- Data component - real-time insights

### Go-to-Market Strategy

- Initial focus: Small/medium medical device companies
- Leveraging existing deep connections and network
- Target trial size: 50-500 participants
- Long-term vision: Software-enabled services moving to vertical integration
- Plan to eventually eliminate traditional CRO model

### Early Traction

- Developed MVP in one week
- Design partner impressed and actively referring to network
- Major wins:
	- Secured pivotal trial bid: $4M TCV over 28 months
	- Wearable sensor validation study: $50K
- Subscription-based pricing model
- Current pipeline worth approximately $16M

### Funding Status

#### Antler Investment

- Total commitment: $500K
	- $200K cash upfront
	- $300K follow-on funding (matched $0.50 on the dollar)
	- No cap or discount on conversion

#### Current Round

- Accelerated fundraising timeline due to market traction
- Targeting $4M formal round
- Already in due diligence with multiple firms

Chat with meeting transcript: https://notes.granola.ai/d/f415e67c-d08a-41bb-853a-acf26d713abc
